ArticleJournal for immunotherapy of cancer2021

Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer.

Carmine Carbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.